Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2011: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2010: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2009: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Research Abstract |
To search for novel bioactive peptides associated with feeding regulation and lifestyle-related diseases, we used the orphan receptor strategy and newly established methods to find some candidates as novel bioactive substances. By using gene deficient mice of ghrelin or neuromed in S(NMS), we demonstrated that endogenous ghrelin suppresses sympathetic nerve activity and improves the prognosis after acute myocardial infarction, and that endogenous NMS may regulate cardiovascular function by activating the sympathetic nervous system.
|